MCHPP MICROCHIP TECHNOLOGY INC

BULLISH Impact: 8/10 8-K
Horizon days Filed May 7, 2026 Processed 13d 3h ago SEC 0000827054-26-000012
8-K Item 2.02: Earnings release
Latest settled — T+5d
MCHPP ▼ -1.68% at T+5d
LONG call ✗ call lost -1.68% · α vs SPY -3.15% · entry $83.74 → $82.33
Next anchor: T+20d in 16d
Currently $79.70 · -4.82% from $83.74 entry
Entry anchored
May 7, 2026
via day open
T+1d
-0.24%
call -0.24% · α -0.47%
$83.54
settled 12d ago
T+5d
-1.68%
call -1.68% · α -3.15%
$82.33
settled 6d ago
T+20d
call — · α —
in 16d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Microchip Technology reported Q4 FY2026 net sales of $1.311B (+35.1% YoY), well above the $1.260B guidance midpoint, and non-GAAP EPS of $0.57, beating the $0.48-$0.52 guidance range. The company raised Q1 FY2027 guidance to $1.455B revenue midpoint and non-GAAP EPS $0.69, signaling accelerating demand recovery across end markets with expanding gross margins.

Key Financial Metrics

Guidance
$1.442 to $1.469 billion
raised
Free Cash Flow
$242.8M
Gross Margin
61%

Actionable Insight

The strong beat and raised guidance suggest the cyclical recovery is accelerating. Traders should watch for continued momentum in the June quarter, as guidance implies 11% sequential revenue growth and further margin expansion toward the 65% long-term target. The stock likely rallies on this report.

Key Facts

  • Q4 net sales $1.311B, +35.1% YoY and +10.6% sequentially, above the high end of guidance
  • Non-GAAP diluted EPS $0.57, beating the $0.48-$0.52 guidance range
  • GAAP diluted EPS $0.21, well above guidance of $0.08-$0.12
  • Non-GAAP gross margin 61.6%, up from 52.0% in the prior-year quarter
  • Q1 FY2027 guidance: net sales $1.442B-$1.469B, non-GAAP EPS $0.67-$0.71, both above consensus
  • Full FY2026 net sales $4.713B, +7.1% YoY; non-GAAP net income $933.9M, +31.8% YoY
  • Inventory reduced to 185 days from 201 days, distributor inventory at 26 days (near low end of historical range)

Financial Impact

Q4 net sales beat by $51M (4.1%) vs guidance midpoint; non-GAAP EPS beat by $0.07 (14%) vs midpoint

revenueepsgross marginoperating margin

Risk Factors

  • Macroeconomic headwinds and tariff uncertainty could slow recovery
  • Inventory normalization may impact near-term factory utilization
  • High debt load ($5.5B) limits financial flexibility

Market Snapshot

Exchange
Nasdaq
Sector
Semiconductors & Related Devices
Analyst Consensus
81% bullish (32 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000827054-26-000012
Document: mchp-20260507.htm0000827054-26-000012
Document: 0000827054-26-000012-index-headers.html0000827054-26-000012
Document: 0000827054-26-000012-index.html0000827054-26-000012
Document: 0000827054-26-000012.txt0000827054-26-000012
8-K Data (Synthetic)0000827054-26-000012
2 reports for MCHPP
Performance horizon
Filters
Rows
Reports for MCHPP — sortable, filterable
Type Now
May 7, 2026
13d ago
8-K
BULLISH ★ 8/10
$83.74 $82.33▼ −1.68%▼ −3.15%$79.70 (−4.82%)
Mar 30, 2026
7w ago
Court Ruling
NEUTRAL ★ 3/10
$54.08 $59.75▲ +10.48%▲ +6.18%$79.70 (+47.37%)
Showing 2 of 2

US Market Status

Market Closed — Opens Thu (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access